5-n-Heneicosylresorcinol (C21:0)

ID147
Name5-n-Heneicosylresorcinol (C21:0)
Synonyms
StructureThumb
Description
GroupPolyphenols
Sub-groupAlkylresorcinols
Exposure sourceDiet
Use
CAS number70110-59-7
PubChem ID155461
ChEBI ID
FooDB IDFDB003029
HMDB IDHMDB31035

Biomarker measurements

Biomarker concentration values

IDParent IDDepthSubject groupPopulationCountryCountry codeCohortTime definitionBiospecimenAnalytical methodBiomarkerBiomarker detailMeasurement sizeDetected (nb)Detected (%)Detected only?Arithmethic meanArithmethic SDGeometric meanGeometric SDMinMin (detected)Percentile_05Percentile_10Percentile_25MedianPercentile_75Percentile_90Percentile_95MaxInterquartile rangeMean 95% CI lowerMean 95% CI upperGMean 95% CI lowerGMean 95% CI upperUnitConverted arithmetic meanConverted geometric meanConverted medianAdjustment typeAdjusted onRegressed onExpressed asPublication
104410471AllAdults from the university campus area in UppsalaSwedenSEbaselinePlasma, fastingGC-MS5-n-Heneicosylresorcinol (C21:0)5127.021.034.0nmol/L27.0 nmol/LCrudeAndersson 2011
105110541AllAdults from the university campus area in UppsalaSwedenSE3 monthsPlasma, fastingGC-MS5-n-Heneicosylresorcinol (C21:0)5129.023.038.0nmol/L29.0 nmol/LCrudeAndersson 2011
345134551All [by diet]Postmenopausal and premenopausal women living in the Helsinki areaFinlandFIPlasma, fastingGC-MS5-n-Heneicosylresorcinol (C21:0)5617.39.5nmol/L17.3 nmol/LCrudeAubertin-Leheudre 2008
346534691VegetariansPostmenopausal and premenopausal women living in the Helsinki areaFinlandFIPlasma, fastingGC-MS5-n-Heneicosylresorcinol (C21:0)2016.98.7nmol/L16.9 nmol/LCrudeAubertin-Leheudre 2008
347934831OmnivoresPostmenopausal and premenopausal women living in the Helsinki areaFinlandFIPlasma, fastingGC-MS5-n-Heneicosylresorcinol (C21:0)3617.59.8nmol/L17.5 nmol/LCrudeAubertin-Leheudre 2008
18551185541AllParticipants without a history of heart diseaseGermanyDEEPIC-Potsdam (European Prospective Investigation into Cancer and Nutrition)baselinePlasma, fastingGC-MS5-n-Heneicosylresorcinol (C21:0)10015.713.518.3nmol/L15.7 nmol/LCrudeMontonen 2010
18557185601AllParticipants without a history of heart diseaseGermanyDEEPIC-Potsdam (European Prospective Investigation into Cancer and Nutrition)4 monthsPlasma, fastingGC-MS5-n-Heneicosylresorcinol (C21:0)10016.113.718.8nmol/L16.1 nmol/LCrudeMontonen 2010
19075190781AllResidents of the Vasterbotten regionSwedenSEVIP cohort (Vasterbotten Intervention Project)baselinePlasma, fastingGC-MS5-n-Heneicosylresorcinol (C21:0)7313.011.115.2nmol/L13.0 nmol/LCrudeLandberg 2013

Intake values

IDParent IDDepthSubject groupPopulationCountryCountry codeCohortTime definitionIntake toolIntake food coverageIntake time coverageIntake assessmentCompoundCompound detailSupplement intakes included?Measurement sizeDetected (nb)Detected (%)Detected only?Arithmethic meanArithmethic SDGeometric meanGeometric SDMinMin (detected)Percentile_05Percentile_10Percentile_25MedianPercentile_75Percentile_90Percentile_95MaxInterquartile rangeMean 95% CI lowerMean 95% CI upperGMean 95% CI lowerGMean 95% CI upperUnitConverted arithmetic meanConverted geometric meanConverted medianAdjustment typeAdjusted onRegressed onExpressed asPublication
101910221AllAdults from the university campus area in UppsalaSwedenSEbaselineSwedish National Food AdministrationWeighed Dietary record (3-day)5-n-Heneicosylresorcinol (C21:0)7210.09.0mg/day10.0 mg/dayCrudeAndersson 2011
103710401AllAdults from the university campus area in UppsalaSwedenSE3 monthsSwedish National Food AdministrationWeighed Dietary record (3-day)5-n-Heneicosylresorcinol (C21:0)729.07.0mg/day9.0 mg/dayCrudeAndersson 2011

Correlation values

Reproducibility values

IDMst. IDSubject groupPopulationCountryCountry codeCohortTime definitionBiological specimenExperimental methodBiomarkerBiomarker detailArithmetic meanGeometric meanMedianUnitAdjusted onReproducibility sizeICCICC 95% CI lowerICC 95% CI upperCV% WSCV% BSVAR WSVAR BSPublication
61069AllAdults from the university campus area in UppsalaSwedenSEbaseline; 3 monthsPlasma, fastingGC-MS5-n-Heneicosylresorcinol (C21:0)nmol/L510.510.310.7Andersson 2011
24318545AllParticipants without a history of heart diseaseGermanyDEEPIC-Potsdam (European Prospective Investigation into Cancer and Nutrition)baseline; 4 monthsPlasma, fastingGC-MS5-n-Heneicosylresorcinol (C21:0)nmol/L1000.470.30.61Montonen 2010
60319067AllResidents of the Vasterbotten regionSwedenSEVIP cohort (Vasterbotten Intervention Project)baseline; 2 yearsPlasma, fastingGC-MS5-n-Heneicosylresorcinol (C21:0)nmol/L730.530.370.69Landberg 2013